Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YBF
|
|||
| Drug Name |
Acyl piperidine derivative 2
|
|||
| Synonyms |
PMID26560530-Compound-44
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ASTON UNIVERSITY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H22BrN3O6
|
|||
| Canonical SMILES |
COC(=O)C1=CC=C(C=C1)COC(=O)N2CCN(CC2)C(=O)CNC(=O)CBr
|
|||
| InChI |
1S/C18H22BrN3O6/c1-27-17(25)14-4-2-13(3-5-14)12-28-18(26)22-8-6-21(7-9-22)16(24)11-20-15(23)10-19/h2-5H,6-12H2,1H3,(H,20,23)
|
|||
| InChIKey |
DHKHYJYAEPJCDA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.